Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Neurological Disorder Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Bayer AG
Novartis AG
Teva Pharmaceutical
Merck & Co
Boehringer Ingelheim GmbH
GlaxoSmithKline plc
By Type:
Hypnotic & Sedative
Analgesics
Others
Antipsychotic
Anticoagulants
By Application:
Clinic
Hospital
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Neurological Disorder Drugs Market Overview 2018-2029
-
1.1 China Neurological Disorder Drugs Industry Development Overview
-
1.2 China Neurological Disorder Drugs Industry Development History
-
1.3 China Neurological Disorder Drugs Industry Market Size (2018-2029)
-
1.4 China Neurological Disorder Drugs Market Analysis by Type from Production Side
-
1.4.1 China Neurological Disorder Drugs Production Volume, Production Value and Growth Rate of Hypnotic & Sedative (2018-2029)
-
1.4.2 China Neurological Disorder Drugs Production Volume, Production Value and Growth Rate of Analgesics (2018-2029)
-
1.4.3 China Neurological Disorder Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.4 China Neurological Disorder Drugs Production Volume, Production Value and Growth Rate of Antipsychotic (2018-2029)
-
1.4.5 China Neurological Disorder Drugs Production Volume, Production Value and Growth Rate of Anticoagulants (2018-2029)
-
1.5 China Neurological Disorder Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Neurological Disorder Drugs Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
1.5.2 China Neurological Disorder Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.6 China Neurological Disorder Drugs Market Analysis by Region
-
1.6.1 North China Neurological Disorder Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Neurological Disorder Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Neurological Disorder Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Neurological Disorder Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Neurological Disorder Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Neurological Disorder Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Neurological Disorder Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Neurological Disorder Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Neurological Disorder Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Neurological Disorder Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Neurological Disorder Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Neurological Disorder Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Neurological Disorder Drugs Industry Development
Chapter 3 Neurological Disorder DrugsIndustry Chain Analysis
-
3.1 Neurological Disorder Drugs Industry Chain
-
3.2 Neurological Disorder Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Neurological Disorder Drugs Market
-
3.3 Neurological Disorder Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Neurological Disorder Drugs Market
Chapter 4 China Neurological Disorder Drugs Market, by Type
-
4.1 China Neurological Disorder Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Neurological Disorder Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Neurological Disorder Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Neurological Disorder Drugs Production Volume and Growth Rate of Hypnotic & Sedative
-
4.5.2 China Neurological Disorder Drugs Production Volume and Growth Rate of Analgesics
-
4.5.3 China Neurological Disorder Drugs Production Volume and Growth Rate of Others
-
4.5.4 China Neurological Disorder Drugs Production Volume and Growth Rate of Antipsychotic
-
4.5.5 China Neurological Disorder Drugs Production Volume and Growth Rate of Anticoagulants
Chapter 5 China Neurological Disorder Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Neurological Disorder Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Neurological Disorder Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Neurological Disorder Drugs Market Size and Growth Rate of Clinic
-
5.5.2 China Neurological Disorder Drugs Market Size and Growth Rate of Hospital
Chapter 6 China Neurological Disorder Drugs Market, by Region
-
6.1 China Neurological Disorder Drugs Production Volume and Production Value, by Region
-
6.2 China Neurological Disorder Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Neurological Disorder Drugs Market Analysis
-
7.1 North China Neurological Disorder Drugs Market, by Type
-
7.2 North China Neurological Disorder Drugs Market, by Application
Chapter 8 Central China Neurological Disorder Drugs Market Analysis
-
8.1 Central China Neurological Disorder Drugs Market, by Type
-
8.2 Central China Neurological Disorder Drugs Market, by Application
Chapter 9 South China Neurological Disorder Drugs Market Analysis
-
9.1 South China Neurological Disorder Drugs Market, by Type
-
9.2 South China Neurological Disorder Drugs Market, by Application
Chapter 10 East China Neurological Disorder Drugs Market Analysis
-
10.1 East China Neurological Disorder Drugs Market, by Type
-
10.2 East China Neurological Disorder Drugs Market, by Application
Chapter 11 Northeast China Neurological Disorder Drugs Market Analysis
-
11.1 Northeast China Neurological Disorder Drugs Market, by Type
-
11.2 Northeast China Neurological Disorder Drugs Market, by Application
Chapter 12 Southwest China Neurological Disorder Drugs Market Analysis
-
12.1 Southwest China Neurological Disorder Drugs Market, by Type
-
12.2 Southwest China Neurological Disorder Drugs Market, by Application
Chapter 13 Northwest China Neurological Disorder Drugs Market Analysis
-
13.1 Northwest China Neurological Disorder Drugs Market, by Type
-
13.2 Northwest China Neurological Disorder Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 Bayer AG
-
14.1.1 Bayer AG Company Profile
-
14.1.2 Bayer AG Neurological Disorder Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Novartis AG
-
14.2.1 Novartis AG Company Profile
-
14.2.2 Novartis AG Neurological Disorder Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Teva Pharmaceutical
-
14.3.1 Teva Pharmaceutical Company Profile
-
14.3.2 Teva Pharmaceutical Neurological Disorder Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Merck & Co
-
14.4.1 Merck & Co Company Profile
-
14.4.2 Merck & Co Neurological Disorder Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Boehringer Ingelheim GmbH
-
14.5.1 Boehringer Ingelheim GmbH Company Profile
-
14.5.2 Boehringer Ingelheim GmbH Neurological Disorder Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 GlaxoSmithKline plc
-
14.6.1 GlaxoSmithKline plc Company Profile
-
14.6.2 GlaxoSmithKline plc Neurological Disorder Drugs Market Performance
-
14.6.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Neurological Disorder Drugs Industry Research Conclusions
-
15.2 Neurological Disorder Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Neurological Disorder Drugs Industry Market Size (2018-2029)
-
Figure China Neurological Disorder Drugs Production Volume, Production Value and Growth Rate of Hypnotic & Sedative (2018-2029)
-
Figure China Neurological Disorder Drugs Production Volume, Production Value and Growth Rate of Analgesics (2018-2029)
-
Figure China Neurological Disorder Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Neurological Disorder Drugs Production Volume, Production Value and Growth Rate of Antipsychotic (2018-2029)
-
Figure China Neurological Disorder Drugs Production Volume, Production Value and Growth Rate of Anticoagulants (2018-2029)
-
Figure China Neurological Disorder Drugs Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
Figure China Neurological Disorder Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure North China Neurological Disorder Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Neurological Disorder Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Neurological Disorder Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Neurological Disorder Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Neurological Disorder Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Neurological Disorder Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Neurological Disorder Drugs Market Size and Growth Rate from 2018-2029
-
Figure Neurological Disorder Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Neurological Disorder Drugs Market Share by Type in 2018
-
Figure China Neurological Disorder Drugs Market Share by Type in 2023
-
Figure China Neurological Disorder Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Neurological Disorder Drugs Production Volume and Growth Rate of Hypnotic & Sedative (2018-2023)
-
Figure China Neurological Disorder Drugs Production Volume and Growth Rate of Analgesics (2018-2023)
-
Figure China Neurological Disorder Drugs Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Neurological Disorder Drugs Production Volume and Growth Rate of Antipsychotic (2018-2023)
-
Figure China Neurological Disorder Drugs Production Volume and Growth Rate of Anticoagulants (2018-2023)
-
Figure China Neurological Disorder Drugs Market Share by Application in 2018
-
Figure China Neurological Disorder Drugs Market Share by Application in 2023
-
Figure China Neurological Disorder Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Neurological Disorder Drugs Market Size and Growth Rate of Clinic (2018-2023)
-
Figure China Neurological Disorder Drugs Market Size and Growth Rate of Hospital (2018-2023)
-
Table China Neurological Disorder Drugs Production Volume by Region (2018-2023)
-
Table China Neurological Disorder Drugs Production Volume Share by Region (2018-2023)
-
Figure China Neurological Disorder Drugs Production Volume Share by Region (2018-2023)
-
Table China Neurological Disorder Drugs Production Value by Region (2018-2023)
-
Table China Neurological Disorder Drugs Production Value Share by Region (2018-2023)
-
Figure China Neurological Disorder Drugs Production Value Share by Region (2018-2023)
-
Table China Neurological Disorder Drugs Sales Volume by Region (2018-2023)
-
Table China Neurological Disorder Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Neurological Disorder Drugs Sales Volume Share by Region (2018-2023)
-
Table China Neurological Disorder Drugs Sales Value by Region (2018-2023)
-
Table China Neurological Disorder Drugs Sales Value Share by Region (2018-2023)
-
Figure China Neurological Disorder Drugs Sales Value Share by Region (2018-2023)
-
Table North China Neurological Disorder Drugs Production Volume by Type (2018-2023)
-
Table North China Neurological Disorder Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Neurological Disorder Drugs Production Volume Share by Type (2018-2023)
-
Table North China Neurological Disorder Drugs Sales Volume by Application (2018-2023)
-
Table North China Neurological Disorder Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Neurological Disorder Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Neurological Disorder Drugs Production Volume by Type (2018-2023)
-
Table Central China Neurological Disorder Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Neurological Disorder Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Neurological Disorder Drugs Sales Volume by Application (2018-2023)
-
Table Central China Neurological Disorder Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Neurological Disorder Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Neurological Disorder Drugs Production Volume by Type (2018-2023)
-
Table South China Neurological Disorder Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Neurological Disorder Drugs Production Volume Share by Type (2018-2023)
-
Table South China Neurological Disorder Drugs Sales Volume by Application (2018-2023)
-
Table South China Neurological Disorder Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Neurological Disorder Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Neurological Disorder Drugs Production Volume by Type (2018-2023)
-
Table East China Neurological Disorder Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Neurological Disorder Drugs Production Volume Share by Type (2018-2023)
-
Table East China Neurological Disorder Drugs Sales Volume by Application (2018-2023)
-
Table East China Neurological Disorder Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Neurological Disorder Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Neurological Disorder Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Neurological Disorder Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Neurological Disorder Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Neurological Disorder Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Neurological Disorder Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Neurological Disorder Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Neurological Disorder Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Neurological Disorder Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Neurological Disorder Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Neurological Disorder Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Neurological Disorder Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Neurological Disorder Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Neurological Disorder Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Neurological Disorder Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Neurological Disorder Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Neurological Disorder Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Neurological Disorder Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Neurological Disorder Drugs Sales Volume Share by Application (2018-2023)
-
Table Bayer AG Company Profile
-
Table Bayer AG Neurological Disorder Drugs Revenue, Price and Gross (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG Neurological Disorder Drugs Revenue, Price and Gross (2018-2023)
-
Table Teva Pharmaceutical Company Profile
-
Table Teva Pharmaceutical Neurological Disorder Drugs Revenue, Price and Gross (2018-2023)
-
Table Merck & Co Company Profile
-
Table Merck & Co Neurological Disorder Drugs Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim GmbH Company Profile
-
Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline plc Company Profile
-
Table GlaxoSmithKline plc Neurological Disorder Drugs Revenue, Price and Gross (2018-2023)
-
